Half Year 2025 Haleon PLC Earnings Call Transcript
Key Points
- Haleon PLC (HLN) reported strong organic profit growth driven by a 160 basis point improvement in gross margin and robust cash flow.
- The company experienced significant growth and market share gains in oral health and digestive health brands like Cannabis and Benefiber.
- Haleon PLC (HLN) has a strong presence in value channels such as dollar and club stores, and e-commerce, with 16 of their top 18 brands having better shares online than offline.
- The company is seeing improved ROI by 4% and continues to focus on the effectiveness of its investments, particularly in A&P and R&D.
- Haleon PLC (HLN) is confident in its medium-term growth prospects, with plans to strengthen its business in the US and continue successful innovations in regions like India and China.
- North America faced challenges with a 2% decline in organic sales growth, attributed to a challenging consumer environment and inventory pressures.
- The smoking cessation category experienced a trade-down effect, impacting growth, and the company does not expect significant improvement in the US market in the near term.
- Advil and Centrum brands faced mixed performance, with Advil losing market share and Centrum experiencing declines in the US.
- The company's volume growth in the US was down 1.8% in Q2, contributing to overall volume challenges.
- The nicotine replacement therapy category, which is a complex joint venture, experienced significant declines, impacting overall group growth by 60 basis points.
Good morning everyone, and welcome to Haleon Half Year 2025 results Q&A conference call.
I'm Jo Russell, Investor Relations, and I'm joined this morning by Brian McNamara, our Chief Executive Officer, and Dawn Allen, our Chief Financial Officer.
Just to remind listens on the call discussions today, the company may make certain forward-looking statements, including those that refer to our estimates, plans and expectations.
This morning's announcement and the company's UK and AC filings for more details, including factors that could lead to actual results to differ materially from those in or implied by such forward-looking statements.
We have posted today's presentation on the website this morning along with the video running through the results in detail. So hopefully you've all had the chance to see that ahead of this call.
And with that, it's open call for Q&A, and I'll hand back to the operator.
Questions & Answers
(Operator Instructions)
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
